INVOKANA® (Canagliflozin) receives positive opinion recommending approval in the European Union for the treatment of adults with type 2 diabetes mellitus
- EMEA Innovative Medicine
- INVOKANA® (canagliflozin) Positive Opinion Recommending approval in the EU
INVOKANA® (canagliflozin) Positive Opinion Recommending approval in the EU
- X (Twitter)
Copy link